MELANIE MARSH: Open Payments
NPI 1659819274 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,147 in 41 payments from 12 companies in 2025. Trend: 2023 $371 · 2024 $555 · 2025 $1,147
Food & beverage: $1,113Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $507 |
| Verona Pharma, Inc. | 7 | $183 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $98 |
| Amgen Inc. | 4 | $82 |
| Regeneron Healthcare Solutions, Inc. | 4 | $67 |
| Insmed, Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| United Therapeutics Corporation | 1 | $31 |
| GENZYME CORPORATION | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: FASENRA, Ohtuvayre, TEZSPIRE, BREZTRI, DUPIXENT, OFEV, JASCAYD, Arikayce.
Industry payments across MO — which companies pay providers there.
